Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_A3,2 | Lung | Primary cancer | 964 | Stromal | 45.3% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__86_A3,3 | Lung | Primary cancer | 1,991 | Tumor/Malignant | 40.0% | 0.73 | 0.59 |
| NSCLC_38242124__IMC__86_A3,5 | Lung | Primary cancer | 2,886 | Tumor/Malignant | 69.3% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__86_A3,6 | Lung | Primary cancer | 1,225 | Tumor/Malignant | 38.8% | 0.77 | 0.51 |
| NSCLC_38242124__IMC__86_A3,8 | Lung | Primary cancer | 1,950 | Tumor/Malignant | 40.7% | 0.64 | 0.72 |
| NSCLC_38242124__IMC__86_A3,9 | Lung | Primary cancer | 1,438 | Stromal | 30.5% | 0.75 | 0.59 |
| NSCLC_38242124__IMC__86_A4,10 | Lung | Primary cancer | 3,091 | Tumor/Malignant | 62.3% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__86_A4,11 | Lung | Primary cancer | 4,264 | Tumor/Malignant | 57.5% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__86_A4,12 | Lung | Primary cancer | 1,518 | Stromal | 37.5% | 0.66 | 0.73 |
| NSCLC_38242124__IMC__86_A4,13 | Lung | Primary cancer | 3,702 | Tumor/Malignant | 67.7% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__86_A4,14 | Lung | Primary cancer | 1,475 | Stromal | 29.8% | 0.61 | 0.71 |
| NSCLC_38242124__IMC__86_A4,2 | Lung | Primary cancer | 3,098 | Stromal | 29.5% | 0.83 | 0.45 |
| NSCLC_38242124__IMC__86_A4,4 | Lung | Primary cancer | 2,095 | Tumor/Malignant | 36.2% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__86_A4,5 | Lung | Primary cancer | 2,889 | Tumor/Malignant | 50.1% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__86_A4,7 | Lung | Primary cancer | 4,264 | Tumor/Malignant | 23.0% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__86_A4,8 | Lung | Primary cancer | 2,515 | Tumor/Malignant | 35.6% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__86_A4,9 | Lung | Primary cancer | 3,185 | Tumor/Malignant | 69.8% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__86_A5,10 | Lung | Primary cancer | 2,294 | Tumor/Malignant | 51.2% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_A5,11 | Lung | Primary cancer | 3,978 | Stromal | 64.6% | 0.91 | 0.23 |
| NSCLC_38242124__IMC__86_A5,12 | Lung | Primary cancer | 2,767 | Tumor/Malignant | 51.6% | 0.95 | 0.21 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_A3,2 | Lung | Primary cancer | 964 | Stromal | 37.2% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__86_A3,3 | Lung | Primary cancer | 1,991 | Tumor/Malignant | 42.9% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__86_A3,5 | Lung | Primary cancer | 2,886 | Tumor/Malignant | 52.7% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_A3,6 | Lung | Primary cancer | 1,225 | Tumor/Malignant | 27.8% | 0.81 | 0.40 |
| NSCLC_38242124__IMC__86_A3,8 | Lung | Primary cancer | 1,950 | Tumor/Malignant | 44.0% | 0.47 | 0.77 |
| NSCLC_38242124__IMC__86_A3,9 | Lung | Primary cancer | 1,438 | Stromal | 23.1% | 0.60 | 0.87 |
| NSCLC_38242124__IMC__86_A4,10 | Lung | Primary cancer | 3,091 | Tumor/Malignant | 65.7% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__86_A4,11 | Lung | Primary cancer | 4,264 | Tumor/Malignant | 57.7% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__86_A4,12 | Lung | Primary cancer | 1,518 | Stromal | 29.6% | 0.71 | 0.68 |
| NSCLC_38242124__IMC__86_A4,13 | Lung | Primary cancer | 3,702 | Tumor/Malignant | 63.9% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__86_A4,14 | Lung | Primary cancer | 1,475 | Tumor/Malignant | 23.0% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__86_A4,2 | Lung | Primary cancer | 3,098 | Stromal | 27.2% | 0.86 | 0.42 |
| NSCLC_38242124__IMC__86_A4,4 | Lung | Primary cancer | 2,095 | Tumor/Malignant | 35.3% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__86_A4,5 | Lung | Primary cancer | 2,889 | Tumor/Malignant | 50.0% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__86_A4,7 | Lung | Primary cancer | 4,264 | Tumor/Malignant | 22.9% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__86_A4,8 | Lung | Primary cancer | 2,515 | Tumor/Malignant | 35.7% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__86_A4,9 | Lung | Primary cancer | 3,185 | Tumor/Malignant | 58.1% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__86_A5,10 | Lung | Primary cancer | 2,294 | Tumor/Malignant | 51.1% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_A5,11 | Lung | Primary cancer | 3,978 | Stromal | 38.6% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_A5,12 | Lung | Primary cancer | 2,767 | Tumor/Malignant | 33.8% | 0.99 | 0.07 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_A3,2 | Lung | Primary cancer | 964 | Fibroblast | 40.5% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__86_A3,3 | Lung | Primary cancer | 1,991 | Tumor/Malignant cell | 55.5% | 0.90 | 0.29 |
| NSCLC_38242124__IMC__86_A3,5 | Lung | Primary cancer | 2,886 | Tumor/Malignant cell | 69.6% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__86_A3,6 | Lung | Primary cancer | 1,225 | Tumor/Malignant cell | 35.7% | 0.78 | 0.49 |
| NSCLC_38242124__IMC__86_A3,8 | Lung | Primary cancer | 1,950 | Fibroblast | 56.5% | 0.49 | 0.81 |
| NSCLC_38242124__IMC__86_A3,9 | Lung | Primary cancer | 1,438 | Fibroblast | 27.9% | 0.29 | 1.09 |
| NSCLC_38242124__IMC__86_A4,10 | Lung | Primary cancer | 3,091 | Tumor/Malignant cell | 66.0% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__86_A4,11 | Lung | Primary cancer | 4,264 | Tumor/Malignant cell | 59.0% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__86_A4,12 | Lung | Primary cancer | 1,518 | Fibroblast | 22.1% | 0.31 | 1.11 |
| NSCLC_38242124__IMC__86_A4,13 | Lung | Primary cancer | 3,702 | Tumor/Malignant cell | 67.3% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__86_A4,14 | Lung | Primary cancer | 1,475 | Tumor/Malignant cell | 27.7% | 0.94 | 0.24 |
| NSCLC_38242124__IMC__86_A4,2 | Lung | Primary cancer | 3,098 | Fibroblast | 33.5% | 0.79 | 0.56 |
| NSCLC_38242124__IMC__86_A4,4 | Lung | Primary cancer | 2,095 | Fibroblast | 37.4% | 0.92 | 0.25 |
| NSCLC_38242124__IMC__86_A4,5 | Lung | Primary cancer | 2,889 | Tumor/Malignant cell | 63.6% | 0.93 | 0.16 |
| NSCLC_38242124__IMC__86_A4,7 | Lung | Primary cancer | 4,264 | Tumor/Malignant cell | 27.4% | 0.91 | 0.31 |
| NSCLC_38242124__IMC__86_A4,8 | Lung | Primary cancer | 2,515 | Tumor/Malignant cell | 42.5% | 0.92 | 0.26 |
| NSCLC_38242124__IMC__86_A4,9 | Lung | Primary cancer | 3,185 | Tumor/Malignant cell | 69.6% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__86_A5,10 | Lung | Primary cancer | 2,294 | Tumor/Malignant cell | 51.4% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__86_A5,11 | Lung | Primary cancer | 3,978 | Fibroblast | 54.6% | 0.91 | 0.26 |
| NSCLC_38242124__IMC__86_A5,12 | Lung | Primary cancer | 2,767 | Tumor/Malignant cell | 50.8% | 0.95 | 0.20 |